The FDA-approved technology to make the current vaccine could be readily adapted to prevent β-HPV infections or specific inhibitors of β-HPVs could be developed and added to sunscreens to precisely target the intersection of UV and viral infection. This evidence concerns the gene PPIB and viral infectious disease.